Skip to main content

Table 5 Pfcrt and Pfmdr-1 mutation and alleles observed in P. falciparum obtained from blood samples collected prior antimalarial treatment

From: Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

 

Bensonville

Saclepea

Kakata

Sinje

Total

n

%

n

%

n

%

n

%

N

%

Mutation

Pfcrt

76 T

29

85.3

19

90.5

20

95.2

12

80.0

80

87.9

Pfmdr-1

86Y

16

47.1

8

38.1

12

57.1

4

26.7

40

44.0

184F

16

47.1

10

47.6

11

52.4

10

66.7

47

51.6

Alleles

Pfcrt

WT

5

14.7

2

9.5

1

4.8

3

20.0

11

12.1

74I/75E/76 T

11

32.4

8

38.1

6

28.6

4

26.7

29

31.9

74I/75E/76 T/362 V

0

0.0

0

0.0

0

0.0

1

6.7

1

1.1

74I/75E/76 T/356 T

16

47.1

8

38.1

10

47.6

6

40.0

40

44.0

74I/75E/76 T/217F/356 T

0

0.0

1

4.8

0

0.0

0

0.0

1

1.1

74I/75E/76 T/141L

0

0.0

1

4.8

2

9.5

0

0.0

3

3.3

74I/75E/76 T/141L/356 T

2

5.9

1

4.8

2

9.5

1

6.7

6

6.6

Total

34

100.00

21

100.00

21

100.00

15

100.00

91

100.00

Pfmdr-1

WT

9

26.5

5

23.8

5

23.8

2

13.3

21

23.1

86Y

6

17.6

5

23.8

5

23.8

1

6.7

17

18.7

184F

9

26.5

8

38.1

4

19.0

9

60.0

30

33.0

86Y/1246Y

3

8.8

1

4.8

0

0.0

2

13.3

6

6.6

86Y/184F

6

17.6

2

9.5

7

33.3

1

6.7

16

17.6

86Y/184F/1276Y

1

2.9

0

0.0

0

0.0

0

0.0

1

1.1

Total

34

100.00

21

100.00

21

100.00

15

100.00

91

100.00